Diseases [C] » Musculoskeletal Diseases [C05] » Rheumatic Diseases
Diseases [C] » Skin and Connective Tissue Diseases [C17] » Connective Tissue Diseases » Rheumatic Diseases
Description
Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement. MeSH
Hierarchy View
Subtype Terms (8)
Arthritis, Juvenile
75 drugs (53 approved, 22 experimental)
Arthritis, Rheumatoid
530 drugs (212 approved, 318 experimental)
Fibromyalgia
120 drugs (75 approved, 45 experimental)
Gout
93 drugs (57 approved, 36 experimental)
Hyperostosis, Sternocostoclavicular
Osteoarthritis
301 drugs (135 approved, 166 experimental)
Polymyalgia Rheumatica
20 drugs (18 approved, 2 experimental)
Rheumatic Fever
11 drugs (5 approved, 6 experimental)
Approved Indicated Drugs (3)
Phase 4 Indicated Drugs (6)
Phase 3 Indicated Drugs (3)
Phase 1 Indicated Drugs (4)
Other Experimental Indicated Drugs (1)
Organization Involved with Phase 4 Indications (11)
Organization Involved with Phase 3 Indications (14)
Organization Involved with Phase 2 Indications (18)
Organization Involved with Phase 1 Indications (7)
Organization Involved with Other Experimental Indications (5)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
